These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32468570)

  • 1. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
    Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV Meets APOBEC: New Players in Head and Neck Cancer.
    Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
    Faden DL; Ding F; Lin Y; Zhai S; Kuo F; Chan TA; Morris LG; Ferris RL
    Oral Oncol; 2019 Sep; 96():140-147. PubMed ID: 31422205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
    Faden DL; Thomas S; Cantalupo PG; Agrawal N; Myers J; DeRisi J
    Oral Oncol; 2017 Nov; 74():8-14. PubMed ID: 29103756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
    Chatfield-Reed K; Gui S; O'Neill WQ; Teknos TN; Pan Q
    Oral Oncol; 2020 Jan; 100():104488. PubMed ID: 31835137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma.
    Ge J; Meng Y; Guo J; Chen P; Wang J; Shi L; Wang D; Qu H; Wu P; Fan C; Zhang S; Liao Q; Zhou M; Xiang B; Wang F; Tan M; Gong Z; Xiong W; Zeng Z
    Nat Commun; 2024 Oct; 15(1):8609. PubMed ID: 39366979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
    Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
    Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
    Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Faden DL; Kuhs KAL; Lin M; Langenbucher A; Pinheiro M; Yeager M; Cullen M; Boland JF; Steinberg M; Bass S; Lewis JS; Lawrence MS; Ferris RL; Mirabello L
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
    Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
    Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of Tumor Antigen-specific T-cell Responses by Immune Checkpoint Blockade in Human Papillomavirus-related Head and Neck Squamous Cell Carcinoma.
    Chikamatsu K; Ida S; Masuda K; Horikawa M; Hoshino N; Takahashi H; Tada H; Oyama T; Takeda S; Tomidokoro Y; Motegi M
    Anticancer Res; 2024 Jul; 44(7):2921-2931. PubMed ID: 38925841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
    J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort.
    Qin T; Zhang Y; Zarins KR; Jones TR; Virani S; Peterson LA; McHugh JB; Chepeha D; Wolf GT; Rozek LS; Sartor MA
    Sci Rep; 2018 Jul; 8(1):11458. PubMed ID: 30061624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
    Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
    Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
    Zeng H; Song X; Ji J; Chen L; Liao Q; Ma X
    BMC Cancer; 2020 Aug; 20(1):796. PubMed ID: 32831060
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
    Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
    Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.